UnitedHealth Group reported strong fourth-quarter and full-year results, exceeding expectations and showcasing resilience amid the pandemic. Management expressed optimism for 2021, highlighting significant anticipated growth in Medicare Advantage, Medicaid, and commercial membership, along with strategic investments like the combination with Change Healthcare. This positive performance and confident outlook are likely to have a positive short-term impact on the stock price.

[1]